Table 2.
Demographic profile of patients with chronic HCV infection and healthy controls
Patients (n = 204) | Healthy controls (n = 350) | |
---|---|---|
Age, mean ± SD (years) | 45 ± 12 | 32 ± 10 |
Male: Female | 126:78 | 240:110 |
ALT (IU/l) | 102 ± 56 | 26.95 ± 4.6 |
Serum albumin (g/dl) | 3.8 ± 0.4 | 3.5 ± 0.5 |
HCV genotype (n = 204) | ||
1 | 33 (16.17%) | – |
2 | 4 (1.47%) | – |
3 | 156 (76.4%) | – |
4 | 11 (5.39%) | – |
Liver biopsy | ||
Fibrosis | ||
Mild | 83 (40.6%) | – |
Severe | 120 (59%) | – |
HAI | ||
Mild | 93 (45.5%) | – |
Severe | 111 (54.4%) | – |
Mode of acquisition of HCV | ||
Blood transfusion | 73 (35%) | – |
Needle-stick injury | 38 (19%) | – |
Medical procedure | 58 (28%) | – |
Unclear | 35 (18%) | – |